HEADER TRANSFERASE/TRANSFERASE INHIBITOR 27-AUG-12 4GS6 TITLE IRREVERSIBLE INHIBITION OF TAK1 KINASE BY 5Z-7-OXOZEAENOL COMPND MOL_ID: 1; COMPND 2 MOLECULE: TAK1-TAB1 FUSION PROTEIN; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: TRANSFORMING GROWTH FACTOR-BETA-ACTIVATED KINASE 1, TGF- COMPND 5 BETA-ACTIVATED KINASE 1, MITOGEN-ACTIVATED PROTEIN KINASE KINASE COMPND 6 KINASE 7-INTERACTING PROTEIN 1, TGF-BETA-ACTIVATED KINASE 1-BINDING COMPND 7 PROTEIN 1, TAK1-BINDING PROTEIN 1; COMPND 8 EC: 2.7.11.25; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MAP3K7, TAK1, TAB1, MAP3K7IP1; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS KINASE FOLD, TAB1 BINDING, CYTOSOL, TRANSFERASE-TRANSFERASE INHIBITOR KEYWDS 2 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR N.A.LARSEN,A.D.FERGUSON,J.WU REVDAT 3 02-AUG-17 4GS6 1 SOURCE REMARK REVDAT 2 27-MAR-13 4GS6 1 JRNL REVDAT 1 23-JAN-13 4GS6 0 JRNL AUTH J.WU,F.POWELL,N.A.LARSEN,Z.LAI,K.F.BYTH,J.READ,R.F.GU, JRNL AUTH 2 M.ROTH,D.TOADER,J.C.SAEH,H.CHEN JRNL TITL MECHANISM AND IN VITRO PHARMACOLOGY OF TAK1 INHIBITION BY JRNL TITL 2 (5Z)-7-OXOZEAENOL. JRNL REF ACS CHEM.BIOL. V. 8 643 2013 JRNL REFN ISSN 1554-8929 JRNL PMID 23272696 JRNL DOI 10.1021/CB3005897 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.2 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 18.75 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 28551 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.223 REMARK 3 R VALUE (WORKING SET) : 0.222 REMARK 3 FREE R VALUE : 0.245 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.050 REMARK 3 FREE R VALUE TEST SET COUNT : 1442 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 14 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.28 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.85 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2968 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2532 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2806 REMARK 3 BIN R VALUE (WORKING SET) : 0.2522 REMARK 3 BIN FREE R VALUE : 0.2709 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.46 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 162 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2334 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 66 REMARK 3 SOLVENT ATOMS : 159 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 52.85 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 67.48 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 8.58160 REMARK 3 B22 (A**2) : 0.75730 REMARK 3 B33 (A**2) : -9.33880 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.397 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.183 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.943 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.930 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2480 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3347 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 832 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : NULL ; NULL ; NULL REMARK 3 ISOTROPIC THERMAL FACTORS : NULL ; NULL ; NULL REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : NULL ; NULL ; NULL REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : NULL ; NULL ; NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.10 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : NULL REMARK 3 OTHER TORSION ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: A 26 A 496 REMARK 3 ORIGIN FOR THE GROUP (A): 22.0209 21.1660 44.7101 REMARK 3 T TENSOR REMARK 3 T11: -0.2736 T22: -0.2470 REMARK 3 T33: -0.1767 T12: -0.0077 REMARK 3 T13: -0.0081 T23: 0.0870 REMARK 3 L TENSOR REMARK 3 L11: 2.9461 L22: 2.4184 REMARK 3 L33: 1.3387 L12: 0.2246 REMARK 3 L13: -0.1960 L23: -0.4525 REMARK 3 S TENSOR REMARK 3 S11: 0.0191 S12: -0.3975 S13: -0.3159 REMARK 3 S21: 0.2763 S22: -0.0280 S23: -0.0367 REMARK 3 S31: 0.1072 S32: -0.0465 S33: 0.0090 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4GS6 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 07-SEP-12. REMARK 100 THE DEPOSITION ID IS D_1000074569. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 03-OCT-08 REMARK 200 TEMPERATURE (KELVIN) : 120 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E+ DW REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU SATURN 944+ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : D*TREK REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 28551 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 18.750 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 6.000 REMARK 200 R MERGE (I) : 0.09400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.28 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 5.90 REMARK 200 R MERGE FOR SHELL (I) : 0.48400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 68.40 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.89 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.55-0.75 M SODIUM CITRATE, 0.2 M REMARK 280 NACL, 0.1 M TRIS, AND 5MM ADENOSINE. ADENOSINE BOUND CRYSTALS REMARK 280 ARE BACKSOAKED WITH INHIBITOR, PH 7.0, VAPOR DIFFUSION, HANGING REMARK 280 DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 2 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X,Y,-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 29.06900 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 66.93350 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 71.06450 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 29.06900 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 66.93350 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 71.06450 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 29.06900 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 66.93350 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 71.06450 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 29.06900 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 66.93350 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 71.06450 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 THR A 178 REMARK 465 ALA A 179 REMARK 465 CYS A 180 REMARK 465 ASP A 181 REMARK 465 ILE A 182 REMARK 465 GLN A 183 REMARK 465 THR A 184 REMARK 465 HIS A 185 REMARK 465 MET A 186 REMARK 465 THR A 187 REMARK 465 ASN A 188 REMARK 465 ASN A 189 REMARK 465 LYS A 190 REMARK 465 GLU A 497 REMARK 465 GLN A 498 REMARK 465 SER A 499 REMARK 465 VAL A 500 REMARK 465 VAL A 501 REMARK 465 THR A 502 REMARK 465 ALA A 503 REMARK 465 PRO A 504 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 39 -139.74 -93.94 REMARK 500 ALA A 57 -15.83 62.93 REMARK 500 ARG A 155 -10.07 72.73 REMARK 500 ASP A 175 77.08 41.40 REMARK 500 SER A 207 -168.06 -129.07 REMARK 500 GLN A 299 -11.12 -145.85 REMARK 500 SER A 469 68.67 -32.76 REMARK 500 PRO A 472 -77.30 -58.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 602 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 603 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 604 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 605 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 606 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 607 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 608 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 609 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 610 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 1FM A 611 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2EVA RELATED DB: PDB REMARK 900 STRUCTURAL BASIS FOR THE INTERACTION OF TAK1 KINASE WITH ITS REMARK 900 ACTIVATING PROTEIN TAB1 DBREF 4GS6 A 31 303 UNP O43318 M3K7_HUMAN 31 303 DBREF 4GS6 A 468 504 UNP Q15750 TAB1_HUMAN 468 504 SEQADV 4GS6 GLY A 26 UNP O43318 EXPRESSION TAG SEQADV 4GS6 SER A 27 UNP O43318 EXPRESSION TAG SEQADV 4GS6 LEU A 28 UNP O43318 EXPRESSION TAG SEQADV 4GS6 HIS A 29 UNP O43318 EXPRESSION TAG SEQADV 4GS6 MET A 30 UNP O43318 EXPRESSION TAG SEQRES 1 A 315 GLY SER LEU HIS MET ILE ASP TYR LYS GLU ILE GLU VAL SEQRES 2 A 315 GLU GLU VAL VAL GLY ARG GLY ALA PHE GLY VAL VAL CYS SEQRES 3 A 315 LYS ALA LYS TRP ARG ALA LYS ASP VAL ALA ILE LYS GLN SEQRES 4 A 315 ILE GLU SER GLU SER GLU ARG LYS ALA PHE ILE VAL GLU SEQRES 5 A 315 LEU ARG GLN LEU SER ARG VAL ASN HIS PRO ASN ILE VAL SEQRES 6 A 315 LYS LEU TYR GLY ALA CYS LEU ASN PRO VAL CYS LEU VAL SEQRES 7 A 315 MET GLU TYR ALA GLU GLY GLY SER LEU TYR ASN VAL LEU SEQRES 8 A 315 HIS GLY ALA GLU PRO LEU PRO TYR TYR THR ALA ALA HIS SEQRES 9 A 315 ALA MET SER TRP CYS LEU GLN CYS SER GLN GLY VAL ALA SEQRES 10 A 315 TYR LEU HIS SER MET GLN PRO LYS ALA LEU ILE HIS ARG SEQRES 11 A 315 ASP LEU LYS PRO PRO ASN LEU LEU LEU VAL ALA GLY GLY SEQRES 12 A 315 THR VAL LEU LYS ILE CYS ASP PHE GLY THR ALA CYS ASP SEQRES 13 A 315 ILE GLN THR HIS MET THR ASN ASN LYS GLY SER ALA ALA SEQRES 14 A 315 TRP MET ALA PRO GLU VAL PHE GLU GLY SER ASN TYR SER SEQRES 15 A 315 GLU LYS CYS ASP VAL PHE SER TRP GLY ILE ILE LEU TRP SEQRES 16 A 315 GLU VAL ILE THR ARG ARG LYS PRO PHE ASP GLU ILE GLY SEQRES 17 A 315 GLY PRO ALA PHE ARG ILE MET TRP ALA VAL HIS ASN GLY SEQRES 18 A 315 THR ARG PRO PRO LEU ILE LYS ASN LEU PRO LYS PRO ILE SEQRES 19 A 315 GLU SER LEU MET THR ARG CYS TRP SER LYS ASP PRO SER SEQRES 20 A 315 GLN ARG PRO SER MET GLU GLU ILE VAL LYS ILE MET THR SEQRES 21 A 315 HIS LEU MET ARG TYR PHE PRO GLY ALA ASP GLU PRO LEU SEQRES 22 A 315 GLN TYR PRO CYS GLN HIS SER LEU PRO PRO GLY GLU ASP SEQRES 23 A 315 GLY ARG VAL GLU PRO TYR VAL ASP PHE ALA GLU PHE TYR SEQRES 24 A 315 ARG LEU TRP SER VAL ASP HIS GLY GLU GLN SER VAL VAL SEQRES 25 A 315 THR ALA PRO HET EDO A 601 4 HET EDO A 602 4 HET EDO A 603 4 HET EDO A 604 4 HET EDO A 605 4 HET EDO A 606 4 HET EDO A 607 4 HET EDO A 608 4 HET EDO A 609 4 HET EDO A 610 4 HET 1FM A 611 26 HETNAM EDO 1,2-ETHANEDIOL HETNAM 1FM (3S,5Z,8S,9S,11E)-8,9,16-TRIHYDROXY-14-METHOXY-3- HETNAM 2 1FM METHYL-3,4,9,10-TETRAHYDRO-1H-2- HETNAM 3 1FM BENZOXACYCLOTETRADECINE-1,7(8H)-DIONE HETSYN EDO ETHYLENE GLYCOL HETSYN 1FM (5Z)-7-OXOZEAENOL FORMUL 2 EDO 10(C2 H6 O2) FORMUL 12 1FM C19 H22 O7 FORMUL 13 HOH *159(H2 O) HELIX 1 1 ASP A 32 LYS A 34 5 3 HELIX 2 2 SER A 67 SER A 69 5 3 HELIX 3 3 GLU A 70 VAL A 84 1 15 HELIX 4 4 SER A 111 GLY A 118 1 8 HELIX 5 5 THR A 126 SER A 146 1 21 HELIX 6 6 LYS A 158 PRO A 160 5 3 HELIX 7 7 SER A 192 MET A 196 5 5 HELIX 8 8 ALA A 197 GLU A 202 1 6 HELIX 9 9 GLU A 208 ARG A 225 1 18 HELIX 10 10 PRO A 235 ASN A 245 1 11 HELIX 11 11 PRO A 256 TRP A 267 1 12 HELIX 12 12 ASP A 270 ARG A 274 5 5 HELIX 13 13 SER A 276 MET A 288 1 13 HELIX 14 14 ARG A 289 PHE A 291 5 3 HELIX 15 15 PHE A 484 GLY A 496 1 13 SHEET 1 A 6 HIS A 29 MET A 30 0 SHEET 2 A 6 LEU A 92 CYS A 96 1 O ALA A 95 N HIS A 29 SHEET 3 A 6 CYS A 101 GLU A 105 -1 O CYS A 101 N CYS A 96 SHEET 4 A 6 LYS A 58 GLN A 64 -1 N ALA A 61 O MET A 104 SHEET 5 A 6 VAL A 49 TRP A 55 -1 N ALA A 53 O VAL A 60 SHEET 6 A 6 ILE A 36 GLY A 43 -1 N GLU A 40 O LYS A 52 SHEET 1 B 2 LEU A 122 PRO A 123 0 SHEET 2 B 2 PRO A 301 CYS A 302 -1 O CYS A 302 N LEU A 122 SHEET 1 C 2 LEU A 162 VAL A 165 0 SHEET 2 C 2 VAL A 170 ILE A 173 -1 O LYS A 172 N LEU A 163 SHEET 1 D 2 LEU A 251 ILE A 252 0 SHEET 2 D 2 ARG A 477 VAL A 478 1 O VAL A 478 N LEU A 251 LINK SG CYS A 174 C42 1FM A 611 1555 1555 1.75 CISPEP 1 ASN A 98 PRO A 99 0 -1.45 CISPEP 2 GLU A 120 PRO A 121 0 4.23 CISPEP 3 GLN A 148 PRO A 149 0 4.06 CISPEP 4 GLY A 234 PRO A 235 0 1.82 SITE 1 AC1 4 TYR A 300 PRO A 301 HIS A 495 HOH A 855 SITE 1 AC2 5 PRO A 258 TYR A 488 TRP A 491 HOH A 718 SITE 2 AC2 5 HOH A 852 SITE 1 AC3 2 ASP A 295 HOH A 821 SITE 1 AC4 7 SER A 272 ARG A 274 PRO A 292 GLU A 486 SITE 2 AC4 7 HOH A 797 HOH A 799 HOH A 800 SITE 1 AC5 4 ALA A 194 LYS A 227 PRO A 228 HOH A 722 SITE 1 AC6 5 SER A 276 ASP A 483 GLU A 486 HOH A 701 SITE 2 AC6 5 HOH A 737 SITE 1 AC7 6 ARG A 248 TRP A 267 LYS A 269 HOH A 761 SITE 2 AC7 6 HOH A 762 HOH A 859 SITE 1 AC8 2 PRO A 297 LEU A 298 SITE 1 AC9 6 GLY A 109 GLY A 167 GLY A 168 HOH A 720 SITE 2 AC9 6 HOH A 854 HOH A 855 SITE 1 BC1 5 LYS A 282 HIS A 468 PRO A 480 VAL A 482 SITE 2 BC1 5 ASP A 483 SITE 1 BC2 15 VAL A 42 ARG A 44 GLY A 45 ALA A 61 SITE 2 BC2 15 MET A 104 GLU A 105 TYR A 106 ALA A 107 SITE 3 BC2 15 PRO A 160 ASN A 161 LEU A 163 CYS A 174 SITE 4 BC2 15 ASP A 175 HOH A 840 HOH A 849 CRYST1 58.138 133.867 142.129 90.00 90.00 90.00 I 2 2 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017200 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007470 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007036 0.00000